We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,851

Hospital walks back study linking aspartame to leukemia
  • Shook Hardy & Bacon LLP
  • USA
  • October 26 2012

Brigham and Women’s Hospital (BWM) has reportedly walked back a recent study claiming to link aspartame with an increased risk of leukemia, non- Hodgkin’s lymphoma (NHL) and other blood-related cancers


FDA Settles Amarin First Amendment Challenge
  • Shook Hardy & Bacon LLP
  • USA
  • March 10 2016

Amarin Pharma and the FDA recently announced a widely expected settlement of First Amendment litigation over restrictions on the company's promotion


First Circuit Affirms Exclusion of Specific Causation Opinion
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2016

The First Circuit recently affirmed the exclusion of plaintiff's expert in a toxic tort claim, leading to summary judgment. See Milward v. Rust-Oleum


California Plaintiffs Settle Class Action Against Hain Celestial Group
  • Shook Hardy & Bacon LLP
  • USA
  • March 24 2016

A California court has approved the class action settlement agreement in a lawsuit alleging that Hain falsely advertised, marketed, sold, and labeled


FDA steps up issuance of warning letters to cosmetic and dietary supplement companies
  • Shook Hardy & Bacon LLP
  • USA
  • April 1 2015

The Food and Drug Administration (FDA) has issued a number of Warning Letters to cosmetic and dietary supplement companies over the last several


ASA upholds complaints against “superfood” claims of chia and flax seeds
  • Shook Hardy & Bacon LLP
  • USA
  • June 13 2014

The U.K. Advertising Standards Authority (ASA), has upheld four complaints challenging whether a TV ad for Bioglan "superfood" chia and flax seeds


Pelman v. McDonald’s Corp.: no class certification for obese teens
  • Shook Hardy & Bacon LLP
  • USA
  • October 29 2010

A judge from the U.S. Court of International Trade, sitting by designation in a New York federal district court, has determined that the obesity-related claims filed in 2002 against McDonald’s Corp. cannot be pursued as a class action


FDA issues final rule on mica-based pearlescent pigments in distilled spirits
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2015

The U.S. Food and Drug Administration (FDA) has issued a final rule allowing "the safe use of mica-based pearlescent pigments prepared from titanium


FDA refuses to re-classify tooth-whitening products as drugs
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2014

The U.S. Food and Drug Administration (FDA) has denied a Citizen Petition asking the agency to re-categorize tooth-whitening products as drugs


FDA Issues Revised Dietary Supplement Labeling Guidance
  • Shook Hardy & Bacon LLP
  • USA
  • April 29 2016

The U.S. Food and Drug Administration (FDA) has issued revisions to the Identity Statement portion of its 2005 Dietary Supplement Labeling Guide. The